Morgan Stanley’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-20,751	Closed	-$204K	–	8264
2021 Q4	$204K	Buy	+20,751	New	+$204K	﹤0.01%	6059